Last Updated: June 26, 2026

Prinston Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PRINSTON INC

PRINSTON INC has ninety-three approved drugs.

There are three tentative approvals on PRINSTON INC drugs.

Summary for Prinston Inc

US Patents:	0
Tradenames:	82
Ingredients:	81
NDAs:	93

Drugs and US Patents for Prinston Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Prinston Inc	IRBESARTAN	irbesartan	TABLET;ORAL	203071-001	Sep 27, 2012	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Prinston Inc	TELMISARTAN AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; telmisartan	TABLET;ORAL	209028-003	Nov 6, 2017	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Prinston Inc	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	214928-002	Dec 30, 2021		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Prinston Inc	POTASSIUM CHLORIDE	potassium chloride	TABLET, EXTENDED RELEASE;ORAL	209922-002	Apr 30, 2019	AB1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Prinston Inc	LISINOPRIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; lisinopril	TABLET;ORAL	076230-002	Jul 1, 2002	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Prinston Inc	PAROXETINE	paroxetine hydrochloride	TABLET;ORAL	203854-001	Oct 31, 2014	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Prinston Inc	PREGABALIN	pregabalin	CAPSULE;ORAL	207883-008	Sep 1, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Prinston Inc

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.